As of 2026-10-02, the Intrinsic Value of Abivax SA (ABVX.PA) is -22.04 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 84.15 EUR, the upside of Abivax SA is -126.19%.
Based on its market price of 84.15 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 126.19%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -22.04 - -22.04 | -22.04 | -126.19% |
| P/E | (21.51) - (28.12) | (25.34) | -130.1% |
| DDM - Stable | (88.34) - 694.65 | 303.16 | 260.3% |
| DDM - Multi | (76.17) - 468.90 | (182.72) | -317.1% |
| Market Cap (mil) | 7,342.09 |
| Beta | 0.63 |
| Outstanding shares (mil) | 87.25 |
| Enterprise Value (mil) | 6,827.26 |
| Market risk premium | 5.82% |
| Cost of Equity | 5.46% |
| Cost of Debt | 5.00% |
| WACC | 5.46% |